diphenyl and lignans
diphenyl has been researched along with lignans in 8 studies
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors
Authors | Studies |
---|---|
Adams, M; Bauer, R; Bodensieck, A; Haslinger, E; Hüfner, A; Kunert, O; Oluwemimo, A; Pferschy-Wenzig, EM; Prettner, E; Schühly, W | 1 |
Chang, JB; Dong, LH; Li, YF; Wang, Q; Wang, SY; Wang, W; Zhao, P | 1 |
Altmann, KH; Anavi-Goffer, S; Gertsch, J; Huefner, A; Kleyer, J; Paredes, JM; Raduner, S; Schuehly, W | 1 |
Dirsch, VM; Dreier, D; Kratena, N; Mihovilovic, MD; Resetar, M; Rycek, L; Schnürch, M; Schuster, D; Temml, V | 1 |
Jung, JK; Kim, SY; Lim, D; Seo, SY; Subedi, L; Yuan, Y | 1 |
Cai, X; Chen, L; Liu, L; Ma, X; Ni, HF; Qiu, X; Wan, L; Ye, H | 1 |
Inoue, M; Itoh, A; Kameda, N; Matsumoto, I; Nakashima, KI; Okamura, M; Tsuboi, T; Yamaguchi, E | 1 |
Cardullo, N; Di Francesco, A; Muccilli, V; Pulvirenti, L; Sciacca, C | 1 |
Other Studies
8 other study(ies) available for diphenyl and lignans
Article | Year |
---|---|
Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
Topics: Arachidonate 5-Lipoxygenase; Biphenyl Compounds; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Humans; Leukocytes; Leukotriene B4; Lignans; Magnolia; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2009 |
[Study on the circular dichroism of (S)- and (R)- Wuweizisu C].
Topics: Biphenyl Compounds; Circular Dichroism; Cyclooctanes; Lignans; Polycyclic Compounds; Spectrum Analysis | 2009 |
Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists.
Topics: Animals; Biphenyl Compounds; Calcium; Cannabinoid Receptor Modulators; Cell Line; Cell Migration Inhibition; Cells, Cultured; Cyclic AMP; Humans; Lignans; Macrophages; Mice; Monocytes; Osteoclasts; Osteogenesis; Plant Extracts; Plants; Receptor, Cannabinoid, CB2; Tumor Necrosis Factor-alpha | 2011 |
Magnolol dimer-derived fragments as PPARγ-selective probes.
Topics: Biphenyl Compounds; Crystallography, X-Ray; Dimerization; Drug Discovery; HEK293 Cells; Humans; Ligands; Lignans; Molecular Docking Simulation; PPAR gamma; Protein Binding; Retinoid X Receptor alpha | 2018 |
Synthesis and anti-neuroinflammatory activity of N-heterocyclic analogs based on natural biphenyl-neolignan honokiol.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Biphenyl Compounds; Cell Line; Dose-Response Relationship, Drug; Heterocyclic Compounds; Lignans; Lipopolysaccharides; Mice; Molecular Structure; Nitric Oxide; Structure-Activity Relationship | 2019 |
Biphenyl-type neolignans from stem bark of Magnolia officinalis with potential anti-tumor activity.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; China; HCT116 Cells; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Magnolia; Molecular Structure; Phytochemicals; Plant Bark | 2020 |
Regulation of adipogenesis through retinoid X receptor and/or peroxisome proliferator-activated receptor by designed lignans based on natural products in 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Bexarotene; Cell Differentiation; Lignans; Mice; PPAR delta; PPAR gamma; Propionates; Retinoid X Receptors | 2023 |
Evaluation of honokiol, magnolol and of a library of new nitrogenated neolignans as pancreatic lipase inhibitors.
Topics: Biphenyl Compounds; Lignans | 2023 |